Nonprofits Urge HHS To Take Over Sarepta's Exondys Patents
A group of nonprofits on Thursday urged the U.S. Department of Health and Human Services to take over five patents covering Sarepta Therapeutics Inc.'s controversially approved and expensive muscular dystrophy drug...To view the full article, register now.
Already a subscriber? Click here to view full article